Literature DB >> 2294675

Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery disease.

M Miller1, L A Mead, P O Kwiterovich, T A Pearson.   

Abstract

The National Cholesterol Education Program treatment guidelines define a plasma total cholesterol of less than 200 mg/dl as "desirable" and recommend no further evaluation of plasma lipid or lipoprotein levels in patients with coronary artery disease (CAD). To determine the prevalence of dyslipidemias in the presence of coexistent CAD and total cholesterol less than or equal to 200 mg/dl, a retrospective case-control study of 1,000 patients who underwent diagnostic coronary angiography was performed. Of 351 patients with total cholesterol less than or equal to 200 mg/dl, 76% of the men (244) and 44% of the women (107) had angiographically demonstrated CAD. In men with CAD and total cholesterol less than or equal to 200 mg/dl, there was a significantly greater prevalence of low levels of high density lipoprotein (HDL) cholesterol (less than or equal to 35 mg/dl), age greater than 50 years, systemic hypertension and diabetes mellitus compared to non-CAD control subjects. In women with CAD and total cholesterol less than or equal to 200 mg/dl, HDL cholesterol less than or equal to 45 mg/dl and diabetes mellitus were also significantly prevalent. Multiple logistic regression analyses revealed that HDL cholesterol, hypertension and age in men and very low density lipoprotein cholesterol in women were significantly associated with CAD after adjustment for other risk factors. These results suggest that a complete lipid and lipoprotein analysis be obtained in all patients with CAD, irrespective of the plasma (or serum) total cholesterol level.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2294675     DOI: 10.1016/0002-9149(90)90017-u

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  18 in total

1.  Do mutations causing low HDL-C promote increased carotid intima-media thickness?

Authors:  Michael Miller; Jeffrey Rhyne; Seung Ho Hong; Gina Friel; Christina Dolinar; Ward Riley
Journal:  Clin Chim Acta       Date:  2006-10-07       Impact factor: 3.786

2.  Service provision and use of anticoagulants in atrial fibrillation.

Authors:  C M Sudlow; H Rodgers; R A Kenny; R G Thomson
Journal:  BMJ       Date:  1995-08-26

3.  The ratio of high-density lipoprotein cholesterol to apolipoprotein A-I predicts myocardial injury following elective percutaneous coronary intervention.

Authors:  Xiao-Lin Li; Jian-Jun Li; Yuan-Lin Guo; Cheng-Gang Zhu; Ping Qing; Na-Qiong Wu; Bo Xu; Run-Lin Gao
Journal:  Clin Cardiol       Date:  2014-08-11       Impact factor: 2.882

4.  Apo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.

Authors:  Zeynep Gungor; Erdembileg Anuurad; Byambaa Enkhmaa; Wei Zhang; Kyoungmi Kim; Lars Berglund
Journal:  Atherosclerosis       Date:  2012-05-08       Impact factor: 5.162

5.  Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.

Authors:  Erdembileg Anuurad; Zeynep Ozturk; Byambaa Enkhmaa; Thomas A Pearson; Lars Berglund
Journal:  J Clin Endocrinol Metab       Date:  2010-03-01       Impact factor: 5.958

6.  Predictive value of ventricular arrhythmias for patency of the infarct-related coronary artery after thrombolytic therapy.

Authors:  A J Six; J H Louwerenburg; J H Kingma; E O Robles de Medina; N M van Hemel
Journal:  Br Heart J       Date:  1991-08

7.  M mode and Doppler echocardiographic assessment of left ventricular diastolic function in primary antiphospholipid syndrome.

Authors:  N Coudray; D de Zuttere; O Blétry; J C Piette; B Wechsler; P Godeau; J C Pourny; Y Lecarpentier; D Chemla
Journal:  Br Heart J       Date:  1995-11

8.  Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease.

Authors:  Lukas Kubala; Guijing Lu; Stephan Baldus; Lars Berglund; Jason P Eiserich
Journal:  Clin Chim Acta       Date:  2008-04-08       Impact factor: 3.786

9.  Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians.

Authors:  Erdembileg Anuurad; Russell P Tracy; Thomas A Pearson; Kyoungmi Kim; Lars Berglund
Journal:  Atherosclerosis       Date:  2008-12-06       Impact factor: 5.162

10.  Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Zhiyuan Zhang; Thomas A Pearson; Lars Berglund
Journal:  Am J Cardiol       Date:  2010-11-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.